Literature DB >> 33083362

Minimal Change Disease and Phenylketonuria in an Adult Patient: The Two Sides of Protein Homeostasis.

Cristina Pires Correia1, Inês Neves1, Paulo Chaves1, Teresa Cardoso1, Roberto Silva1, Jorge Almeida1.   

Abstract

Phenylketonuria (PKU), the most common inborn error of amino acid metabolism, has been associated with an increased risk of renal impairment, the reason for which is not fully understood. We report the case of a 33-year-old female patient diagnosed with PKU in adulthood after suspicion of the disease in her daughter. The diagnostic approach revealed proteinuria, and minimal change disease (MCD) was identified. Therapeutic measures and follow-up are discussed. The possible link between these two disorders is interesting. Attenuated developmental delay of untreated PKU could be explained by the decreased accumulation of phenylalanine secondary to proteinuria. On the other hand, MCD may be a possible, although as yet unreported, pathophysiological mechanism explaining the renal repercussions that have been found in adult PKU patients, who should be screened for proteinuria. LEARNING POINTS: Phenylketonuria (PKU) is associated with renal impairment so patients with PKU should be periodically screened for proteinuria because podocytopathies, such as minimal change disease (MCD), may be an underlying misdiagnosed condition.MCD in adults demands tight surveillance in case of severe complications including nephrotic syndrome, haematuria and acute kidney injury, and although remission with glucocorticoid therapy is typical, 50-75% of patients will relapse.MCD may be a previously unreported cause of proteinuria and renal involvement in adult patients with PKU, where control of hypertension and moderation of protein overload are essential. © EFIM 2020.

Entities:  

Keywords:  Minimal change disease (MCD); nephrotic syndrome; phenylalanine; phenylketonuria (PKU); proteinuria

Year:  2020        PMID: 33083362      PMCID: PMC7546553          DOI: 10.12890/2020_001821

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  5 in total

1.  Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.

Authors:  Barbara K Burton; Kyle Bradford Jones; Stephen Cederbaum; Fran Rohr; Susan Waisbren; Debra E Irwin; Gilwan Kim; Joshua Lilienstein; Ignacio Alvarez; Elaina Jurecki; Harvey Levy
Journal:  Mol Genet Metab       Date:  2018-09-12       Impact factor: 4.797

Review 2.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

Review 3.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

4.  Chronic kidney disease in adolescent and adult patients with phenylketonuria.

Authors:  Julia B Hennermann; Sylvia Roloff; Jutta Gellermann; Ilka Vollmer; Elke Windt; Barbara Vetter; Ursula Plöckinger; Eberhard Mönch; Uwe Querfeld
Journal:  J Inherit Metab Dis       Date:  2012-11-09       Impact factor: 4.982

5.  Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease.

Authors:  Hajeong Lee; Kyung Don Yoo; Yun Kyu Oh; Dong Ki Kim; Kook-Hwan Oh; Kwon Wook Joo; Yon Su Kim; Curie Ahn; Jin Suk Han; Chun Soo Lim
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.